Organigram Holdings Inc. EV/FCF

EV/FCF of OGI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/FCF growth rates and interactive chart. A valuation metric that measures the enterprise value of a stock compared to its free cash flow. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low EV/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. EV/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.


Highlights and Quick Summary

Current EV/FCF of Organigram Holdings Inc. is -19.92 (as of August 31, 2021)
  • EV/FCF for the quarter ending February 28, 2022 was -8.35 (a -23.69% decrease compared to previous quarter)
  • Year-over-year quarterly EV/FCF decreased by -54.16%
  • Annual EV/FCF for 2021 was -19.92 (a 640.35% increase from previous year)
  • Annual EV/FCF for 2020 was -2.69 (a -51.98% decrease from previous year)
  • Annual EV/FCF for 2019 was -5.6 (a -Infinity% decrease from previous year)
Visit stockrow.com/OGI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/FCF of Organigram Holdings Inc.

Most recent EV/FCFof OGI including historical data for past 10 years.

Interactive Chart of EV/FCF of Organigram Holdings Inc.

Organigram Holdings Inc. EV/FCF for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -8.35
2021 -10.94 -19.92 -18.21 -21.3 -19.92
2020 -4.61 -2.69 -3.05 -3.29 -2.69
2019 -3.95 -5.6 -8.44 0.0 -5.6
2018 0.0 0.0 0.0
2017 0.0
2016 0.0

Business Profile of Organigram Holdings Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic